{"id":"investigational-sipv","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an inactivated poliovirus vaccine, sIPV contains chemically inactivated poliovirus particles that trigger both humoral (antibody) and cellular immune responses without causing disease. The vaccine is designed to provide protection against all three serotypes of poliovirus, preventing paralytic poliomyelitis and contributing to polio eradication efforts.","oneSentence":"sIPV is an inactivated poliomyelitis vaccine that stimulates immune responses against poliovirus types 1, 2, and 3 to prevent poliomyelitis infection.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:16:58.159Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3"}]},"trialDetails":[{"nctId":"NCT06346834","phase":"PHASE4","title":"Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2024-05-20","conditions":"Poliomyelitis","enrollment":200},{"nctId":"NCT05386810","phase":"PHASE3","title":"Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-11-05","conditions":"Poliomyelitis","enrollment":1572},{"nctId":"NCT04989231","phase":"","title":"An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2021-09-09","conditions":"Poliomyelitis","enrollment":450},{"nctId":"NCT04386707","phase":"PHASE3","title":"Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-05-11","conditions":"Poliomyelitis","enrollment":1300},{"nctId":"NCT04618783","phase":"NA","title":"Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2019-07-20","conditions":"Poliomyelitis","enrollment":250},{"nctId":"NCT04264546","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2017-11-24","conditions":"Polio","enrollment":60},{"nctId":"NCT04264598","phase":"PHASE1","title":"Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2017-08-21","conditions":"Polio","enrollment":100},{"nctId":"NCT03902054","phase":"PHASE2","title":"Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2017-12-28","conditions":"Polio and Post-Polio Syndrome","enrollment":600},{"nctId":"NCT03822767","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a \"2+1\"Sequential Schedule With bOPV in Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2018-06-12","conditions":"Poliomyelitis","enrollment":240},{"nctId":"NCT03822754","phase":"PHASE3","title":"A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2018-06-06","conditions":"Poliomyelitis","enrollment":240},{"nctId":"NCT03526978","phase":"PHASE3","title":"An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2017-08-08","conditions":"Poliomyelitis","enrollment":1200},{"nctId":"NCT02985320","phase":"PHASE1, PHASE2","title":"Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2016-10","conditions":"Poliomyelitis","enrollment":708}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Investigational sIPV","genericName":"Investigational sIPV","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"sIPV is an inactivated poliomyelitis vaccine that stimulates immune responses against poliovirus types 1, 2, and 3 to prevent poliomyelitis infection. Used for Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}